Shortage reports
Actual shortage:
11 (3%)
Anticipated shortage:
2 (1%)
Avoided shortage:
5 (1%)
Resolved:
355 (95%)
373
Discontinuation Reports
To be discontinued:
0 (0%)
Discontinued:
2 (100%)
Reversed:
0 (0%)
2
51 (14%)
3 (23%)
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| ROPIVACAINE HYDROCHLORIDE INJECTION, USP | 10 mg/mL | Solution | Resolved | 2018-06-06 | 2019-03-01 | 51686 |
| ROPIVACAINE HYDROCHLORIDE INJECTION, USP | 5 mg/mL | Solution | Resolved | 2018-06-06 | 2019-09-13 | 51683 |
| ROPIVACAINE HYDROCHLORIDE INJECTION, USP | 2MG | SOLUTION | Resolved | 2022-04-13 | 2022-07-15 | 158786 |
| ROPIVACAINE HYDROCHLORIDE INJECTION, USP | 2MG | SOLUTION | Resolved | 2024-11-21 | 2025-02-08 | 243515 |
| ROPIVACAINE HYDROCHLORIDE INJECTION, USP | 2MG | SOLUTION | Resolved | 2025-03-13 | 2025-03-21 | 252534 |
| ROPIVACAINE HYDROCHLORIDE INJECTION, USP | 10MG | SOLUTION | Resolved | 2022-04-13 | 2022-08-29 | 158792 |
| ROPIVACAINE HYDROCHLORIDE INJECTION, USP | 2MG | SOLUTION | Resolved | 2025-08-18 | 2025-09-10 | 265518 |
| ROPIVACAINE HYDROCHLORIDE INJECTION, USP | 2MG | SOLUTION | Resolved | 2025-10-01 | 2025-12-05 | 268276 |
| ROPIVACAINE HYDROCHLORIDE INJECTION, USP | 2MG | SOLUTION | Resolved | 2025-11-15 | 2025-12-05 | 271950 |
| ROPIVACAINE HYDROCHLORIDE INJECTION, USP | 2MG | SOLUTION | Actual shortage | 2025-12-22 | 2026-01-02 | 274900 |
| ROPIVACAINE HYDROCHLORIDE INJECTION, USP | 10MG | SOLUTION | Resolved | 2022-04-13 | 2022-09-01 | 158789 |
| ROPIVACAINE HYDROCHLORIDE INJECTION, USP | 10MG | SOLUTION | Resolved | 2021-10-21 | 2021-12-31 | 147731 |
| ROPIVACAINE HYDROCHLORIDE INJECTION, USP | 2MG | SOLUTION | Actual shortage | 2025-12-22 | 2026-01-02 | 274903 |
| ROPIVACAINE HYDROCHLORIDE INJECTION, USP | 10MG | SOLUTION | Resolved | 2021-03-26 | 2021-04-16 | 136455 |
| ROPIVACAINE HYDROCHLORIDE INJECTION, USP | 10MG | SOLUTION | Resolved | 2021-03-26 | 2021-04-16 | 136460 |
| ROPIVACAINE HYDROCHLORIDE INJECTION, USP | 2mg/mL | Solution | Resolved | 2018-06-06 | 2018-10-02 | 51677 |
| ROPIVACAINE HYDROCHLORIDE INJECTION, USP | 10MG | SOLUTION | Resolved | 2023-01-16 | 2023-04-04 | 181154 |
| ROPIVACAINE HYDROCHLORIDE INJECTION, USP | 10MG | SOLUTION | Resolved | 2023-01-16 | 2023-11-17 | 181157 |
| ROPIVACAINE HYDROCHLORIDE INJECTION, USP | 10MG | SOLUTION | Resolved | 2025-05-15 | 2025-09-18 | 257446 |
| ROPIVACAINE HYDROCHLORIDE INJECTION, USP | 10MG | SOLUTION | Resolved | 2025-05-15 | 2025-12-09 | 257455 |
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| PIPERACILLIN AND TAZOBACTAM FOR INJECTION | 4.5G 36G | POWDER FOR SOLUTION | Discontinued | 2024-08-13 | 2024-08-20 | 235203 |
| SODIUM BICARBONATE INJECTION, USP | 42MG | SOLUTION | Discontinued | 2024-10-03 | 2024-10-03 | 239180 |
Showing 1 to 2 of 2